Price
Target price
€30.00
€30.00
0.670%
0.2
0.670%
€45.73
17.04.24 / Stuttgart Stock Exchange
WKN: 897013 / Symbol: IART / Name: Integra / Stock / Healthcare Equipment & Supplies / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Integra LifeSciences Holdings Corp Stock
Integra LifeSciences Holdings Corp gained 0.670% compared to yesterday.
Based on 3 Buy predictions and 3 Sell predictions the sentiment towards Integra LifeSciences Holdings Corp is rather balanced.
As a result the target price of 45 € shows a positive potential of 50.0% compared to the current price of 30.0 € for Integra LifeSciences Holdings Corp.
Pros and Cons of Integra LifeSciences Holdings Corp in the next few years
Pros
?
B****
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Cons
?
M***** P*******
?
G***** c******* t* c**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Integra LifeSciences Holdings Corp vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Integra LifeSciences Holdings Corp | 0.670% | -4.487% | -6.875% | -44.299% | -24.365% | -50.333% | -32.769% |
| Neogen Corp. | 1.800% | -5.932% | -19.565% | -23.448% | -39.344% | -71.538% | -55.533% |
| Bio-Rad Labs Inc. A | -0.220% | -11.522% | -11.089% | -38.158% | -7.153% | -48.076% | - |
| Merit Medical Systems | -1.470% | 2.256% | 3.817% | -2.158% | 0.000% | 34.653% | 25.670% |
Comments
Integra LifeSciences Holdings Co. (NASDAQ: IART) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for IART provided by MarketBeat
Integra LifeSciences Holdings Co. (NASDAQ: IART) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $49.00 price target on the stock, up previously from $40.00.
Show more
Ratings data for IART provided by MarketBeat
Integra LifeSciences Holdings Co. (NASDAQ: IART) is now covered by analysts at CL King. They set a "buy" rating and a $50.00 price target on the stock.
Show more
Ratings data for IART provided by MarketBeat